Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): A systematic analysis of expert opinion

F. C. Lowe, J. Batista, R. Berges, E. Chartier-Kastler, G. Conti, F. Desgrandchamps, K. Dreikorn, M. O'Leary, M. Perez, M. Speakman, J. Trachtenberg, A. Tubaro, B. Meesen, L. Smets, H. Stoevelaar

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Disease progression has become an important issue for the management of lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH). Although several risk factors have been identified, no specific patient risk profiles have been established that can be useful in the day-to-day management of LUTS/BPH. In this study, an international panel of urologists developed a risk classification based on the attribution of a risk score to 243 unique patient profiles. From the perspective of clinical decision making, it was concluded that postvoid residual, symptom severity and maximum flow rate are the most relevant determinants of the risk of disease progression.

Original languageEnglish (US)
Pages (from-to)206-209
Number of pages4
JournalProstate Cancer and Prostatic Diseases
Volume8
Issue number3
DOIs
StatePublished - Sep 1 2005
Externally publishedYes

Keywords

  • Benign prostatic hyperplasia
  • Disease progression
  • Lower urinary tract symptoms
  • Risk factors

ASJC Scopus subject areas

  • Oncology
  • Urology
  • Cancer Research

Fingerprint Dive into the research topics of 'Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): A systematic analysis of expert opinion'. Together they form a unique fingerprint.

  • Cite this

    Lowe, F. C., Batista, J., Berges, R., Chartier-Kastler, E., Conti, G., Desgrandchamps, F., Dreikorn, K., O'Leary, M., Perez, M., Speakman, M., Trachtenberg, J., Tubaro, A., Meesen, B., Smets, L., & Stoevelaar, H. (2005). Risk factors for disease progression in patients with lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH): A systematic analysis of expert opinion. Prostate Cancer and Prostatic Diseases, 8(3), 206-209. https://doi.org/10.1038/sj.pcan.4500806